Entavir 0.5
Entavir (Baraclude) 0.5 Mg – 10 tablet

Entavir (Baraclude) 0.5 Mg – 10 tablet


Each Entavir contains .5 mg Entecavir 10 tablets per box. Entavir is a powerful medicine used to treat hepatitis B infection.

ATC Classification: J05AF10
Active Ingrediant Entecavir
Generic Name: Entavir
Manufacturer: Cipla Ltd
Strength: 0.5 Mg
Dosage Type: Tablet
Packaging Type: Foil in Box
Contains: 10 Tab


What is this drug used for?

• It is used to treat hepatitis B infection.

Frequently reported side effects of this drug

• Headache

• Dizziness

• Nausea

• Loss of strength and energy

Other side effects of this drug: Talk with your doctor right away if you have any of these signs of:

• Lactic acidosis like fast breathing, fast heartbeat, abnormal heartbeat, vomiting, fatigue, shortness of breath, severe loss of strength and energy, severe dizziness, feeling cold, or muscle pain or cramps.

• Liver problems like dark urine, fatigue, lack of appetite, nausea, abdominal pain, light-colored stools, vomiting, or yellow skin.

• Signs of a significant reaction like wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat.

Note: This is not a comprehensive list of all side effects. Talk to your doctor if you have questions.



(en TE ka veer)


Generic Availability: US

May be product dependent


Storage and Stability

Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Protect from light. After opening, oral solution can be used up to expiration date on the bottle.


Adverse Reactions

As reported with adult patients, unless otherwise noted.

Central nervous system: Fatigue, headache

Dermatologic: Skin rash

Endocrine & metabolic: Glycosuria, hyperglycemia

Gastrointestinal: Abdominal pain (children and adolescents), diarrhea, dyspepsia, increased serum lipase, nausea, unpleasant taste (children and adolescents), vomiting

Genitourinary: Hematuria

Hepatic: Increased serum alanine aminotransferase, increased serum bilirubin

Renal: Increased serum creatinine

<1%, postmarketing, and/or case reports: Alopecia, anaphylactoid shock, dizziness, drowsiness, hepatomegaly, hepatomegaly with steatosis, hypoalbuminemia, increased serum transaminases, insomnia, lactic acidosis, macular edema (Muqit 2011), thrombocytopenia



Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , , , , , , , , , , , , , ,


Dosage Type

Packaging Type


There are no reviews yet.

Be the first to review “Entavir (Baraclude) 0.5 Mg – 10 tablet”

Your email address will not be published.